Atraumatic hernia repair using TISSIUM™ system
Official title: ALPHA: A Pilot Study to Evaluate the Initial Safety and Performance of the TISSIUM™ Atraumatic Hernia Repair System (TAHRS) for Laparoscopic Hernia Repair
Run by Tissium · NCT06042205 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new hernia repair system to see if it safely and effectively helps people with certain types of hernias during laparoscopic surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Tissium Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 5 sites (Genk, Limburg and 4 other locations) |
| Trial ID | NCT06042205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a midline primary ventral, umbilical, or incisional hernia scheduled for laparoscopic repair.
✕Probably not a fit
Patients with a BMI over 40, known hypersensitivity to the device materials, or those with multiple hernia defects may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to evaluate the clinical safety and performance of the TISSIUM™ Atraumatic Hernia Repair System (TAHRS) in patients undergoing laparoscopic repair for midline primary ventral, umbilical, or incisional hernias. Participants will be assessed for their ability to have their hernia repaired with a specific overlap of mesh. The study will capture preliminary data on the effectiveness and safety of this innovative repair system.
Why it matters
Potential benefit: If successful, this approach could provide a safer and more effective method for hernia repair, potentially reducing recovery time and complications.
How similar studies have gone: While this study explores a novel approach, similar interventions in hernia repair have shown promise in improving outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: 1. Subject is 18 years old or older; 2. Patient willing and able to provide a signed Patient Informed Consent Form; 3. Has a midline primary ventral, umbilical or incisional hernia; 4. Scheduled for a laparoscopic IPOM hernia repair; 5. Hernia can be successfully repaired with at least a 5 cm overlap of the mesh on all sides of the defect Key Exclusion Criteria: 1. Patient has a known or suspected hypersensitivity to the constituent polymer of the investigational device, mesh, or other surgical products (e.g., sutures); 2. BMI \> 40; 3. Patient is a current smoker, defined as self-reporting smoking more than 1 cigarette per day; 4. Patient is taking systemic immunosuppressive medications, systemic steroids, or chemotherapy at the time of informed consent; 5. Patient is pregnant, plans to become pregnant during the study period, or is breastfeeding; 6. Patient with Type 1 or uncontrolled Type 2 Diabetes Mellitus; 7. Patient has more than one hernia defect (to be confirmed intraoperatively);
Where it's running
-
Ziekenhuis Oost-Limburg [ZOL]
Genk, Limburg, Belgium Recruiting -
Imelda Hospital
Bonheiden, Belgium Recruiting -
CHU UCL Namur
Yvoir, Belgium Recruiting -
Universitary Hospital Virgen Macarena
Seville, Spain Recruiting -
AZ Sint-Jan
Ruddershove, Belgium Active not recruiting
Study contacts
- Study coordinator: Sr. Manager, Clinical Affairs
- Email: ntrinward@tissium.com
- Phone: +1 857-408-0709
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PrioritiesAI: A chat tool to help older adults with hernia decide what matters most for surgery
This study tests an AI-powered chat assistant to help people with hernia clearly express and communicate their health goals for elective surgery.
-
Pre‑surgery optimisation for ventral hernia repair
This trial tests whether a structured pre-surgery programme to boost activity, encourage weight loss, and optimise other health problems helps adults with 4–8 cm ventral hernias have fewer complications after surgery.
-
Mesh fixation for ventral hernia repair using ECLIPSIUM device
This trial tests whether the ECLIPSIUM bioresorbable fixation system can securely hold mesh in ventral hernia repairs and reduce recurrences compared with bioresorbable tacks.
-
Pre-surgery BOTOX to help close very large ventral hernias
This test tries a one-time image-guided BOTOX injection into the side abdominal muscles 3–7 weeks before open repair to see if it helps surgeons fully close very large ventral hernias in adults.
-
Long-term outcomes after FETO for severe left or right congenital diaphragmatic hernia
This trial will test whether performing FETO in fetuses with isolated severe left or right CDH helps more babies survive to hospital discharge and have fewer long-term problems than standard care.
-
Patient outcomes for hernia surgery at Shouldice Hospital
This study looks at how patients feel after having hernia surgery at Shouldice Hospital to see how well they recover and how satisfied they are with their care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.